case series

Clinical Outcomes of Orchiopexy for Undescended Testes in Syndromic Patients with Developmental Delay, Genetic Syndromes, and Congenital Anomalies

Austin W. Lee1, Laurence S. Baskin1*

Department of Urology, University of California-San Francisco, San Francisco, California, USA

*Corresponding author: Laurence S. Baskin, Chief Pediatric Urology UCSF Benioff Children’s Hospitals, Department of Urology, University of California-San Francisco, San Francisco, California, USA

Received Date: 25 February 2023

Accepted Date: 03 March 2023

Published Date: 08 March 2023

Citation: Lee AW, Baskin LS (2023) Clinical Outcomes of Orchiopexy for Undescended Testes in Syndromic Patients with Developmental Delay, Genetic Syndromes, and Congenital Anomalies. Arch Pediatr 8: 250. DOI: https://doi.org/10.29011/2575-825X.100250

Abstract

Objectives: To determine patient characteristics and clinical outcomes during and after orchiopexy in syndromic children with either developmental delay, genetic syndromes, or congenital anomalies compared to age matched controls. Study Design: This is a retrospective cohort study of patients ≤ 18 years old who underwent orchiopexy at UCSF Benioff Children’s Hospitals between 2012-2020 and were identified as syndromic patients with either developmental delay, molecular testing-confirmed genetic syndromes or known congenital anomalies, compared to an age-matched non syndromic control group. Intra-operative covariates including procedure staging, surgical approach, undescended testes location, estimated blood loss, intra-operative complication occurrence, orchiopexy laterality and post-operative covariates including complication occurrence were gathered through electronic chart review. Differences in continuous and categorical variables were assessed using Mann-Whitney and Chi-squared tests, respectively. Results: Our study yielded 825 total patients undergoing orchiopexy, of which 16% were defined as syndromic. 67 patients had developmental delay, 38 patients had a defined genetic syndrome, and 25 patients had an associated congenital anomaly. These patients were compared to 60 age matched non-syndromic control patients undergoing orchiopexy. Patients with unspecified developmental delay more often underwent bilateral orchiopexy compared to the control group (43% v. 23%, p=0.02). Patients with a genetic syndrome were less likely to have a single stage procedure (92% v. 100%, p=0.03) and more likely to undergo bilateral orchiopexy (45% v. 23%, p=0.03) compared to the control group. There were no differences in rate of bilateral orchiopexy and single stage procedures between patients with a congenital anomaly and the control group. There was no difference in intraoperative or post-operative complications or clinical outcomes between the three syndromic groups and control group. Conclusions: Clinical outcomes were no different between patients with syndromes undergoing orchiopexy compared to non-syndromic children. Patients with non-specific developmental delay or a genetic syndrome more often had bilateral orchiopexies. Patients with a genetic syndrome were also less likely to have a single stage procedure. Orchiopexy in syndromic patients undergoing orchiopexy is safe with comparable outcomes to non-syndromic patients.

Keywords: Orchiopexy; Testis; Syndromic; Outcomes; Pediatrics

© by the Authors & Gavin Publishers. This is an Open Access Journal Article Published Under Attribution-Share Alike CC BY-SA: Creative Commons Attribution-Share Alike 4.0 International License. With this license, readers can share, distribute, download, even commercially, as long as the original source is properly cited. Read More About Open Access Policy.

Archives of Pediatrics

Update cookies preferences